In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens

Background: L7/L12 is a protective antigen conserved in main Brucella pathogens and is considered as potential vaccine candidate. Outer membrane protein 2b is an immunogen conserved in all Brucella pathogens. Materials and Methods: The purpose of the current study was to in silico design a L7/L12-SO...

Full description

Bibliographic Details
Main Authors: Maryam Golshani, Melina Ghasemian, Nematollah Gheibi, Saeid Bouzari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=21;epage=21;aulast=Golshani
_version_ 1819098353614454784
author Maryam Golshani
Melina Ghasemian
Nematollah Gheibi
Saeid Bouzari
author_facet Maryam Golshani
Melina Ghasemian
Nematollah Gheibi
Saeid Bouzari
author_sort Maryam Golshani
collection DOAJ
description Background: L7/L12 is a protective antigen conserved in main Brucella pathogens and is considered as potential vaccine candidate. Outer membrane protein 2b is an immunogen conserved in all Brucella pathogens. Materials and Methods: The purpose of the current study was to in silico design a L7/L12-SOmp2b fusion protein and in vitro production of the chimera. Two possible fusion forms, L7/L12-SOmp2b and SOmp2b-L7/L12, were subjected to in silico modeling and analysis. Cloning and expression of the fusion protein has been done in the pET28a vector and Escherichia coli Bl21 (DE3), respectively. Results: Analysis and validation of the fusion proteins three-dimensional models showed that both models are in the range of native proteins. However, L7/L12-SOmp2b structure was more valid than the SOmp2b-L7/L12 model and subjected to in vitro production. The major histocompatibility complex II (MHC-II) epitope mapping using Immune Epitope DataBase indicated that the model contained good MHC-II binders. The L7/L12-Omp2b coding sequence was cloned in pET28a vector. The fusion was successfully expressed in E. coli BL21 by induction with isopropyl-β-d-thiogalactopyranoside. The rL7/L12-SOmp2b was purified with Ni-NTA column. The yield of the purified rL7/L12-SOmp2b was estimated by Bradford method to be 240 μg/ml of the culture. Western blot analysis revealed a specific reactivity with purified rL7/L12-SOmp2b produced in E. coli cells and showed the expression in the prokaryotic system. Conclusions: Our data indicates that L7/L12-SOmp2b fusion protein has a potential to induce both B- and T-cell-mediated immune responses and it can be evaluated as a new subunit vaccine candidate against brucellosis.
first_indexed 2024-12-22T00:29:38Z
format Article
id doaj.art-65e84019480449e581945a269b7286d1
institution Directory Open Access Journal
issn 2277-9175
language English
last_indexed 2024-12-22T00:29:38Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-65e84019480449e581945a269b7286d12022-12-21T18:44:58ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752018-01-0171212110.4103/abr.abr_10_17In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b AntigensMaryam GolshaniMelina GhasemianNematollah GheibiSaeid BouzariBackground: L7/L12 is a protective antigen conserved in main Brucella pathogens and is considered as potential vaccine candidate. Outer membrane protein 2b is an immunogen conserved in all Brucella pathogens. Materials and Methods: The purpose of the current study was to in silico design a L7/L12-SOmp2b fusion protein and in vitro production of the chimera. Two possible fusion forms, L7/L12-SOmp2b and SOmp2b-L7/L12, were subjected to in silico modeling and analysis. Cloning and expression of the fusion protein has been done in the pET28a vector and Escherichia coli Bl21 (DE3), respectively. Results: Analysis and validation of the fusion proteins three-dimensional models showed that both models are in the range of native proteins. However, L7/L12-SOmp2b structure was more valid than the SOmp2b-L7/L12 model and subjected to in vitro production. The major histocompatibility complex II (MHC-II) epitope mapping using Immune Epitope DataBase indicated that the model contained good MHC-II binders. The L7/L12-Omp2b coding sequence was cloned in pET28a vector. The fusion was successfully expressed in E. coli BL21 by induction with isopropyl-β-d-thiogalactopyranoside. The rL7/L12-SOmp2b was purified with Ni-NTA column. The yield of the purified rL7/L12-SOmp2b was estimated by Bradford method to be 240 μg/ml of the culture. Western blot analysis revealed a specific reactivity with purified rL7/L12-SOmp2b produced in E. coli cells and showed the expression in the prokaryotic system. Conclusions: Our data indicates that L7/L12-SOmp2b fusion protein has a potential to induce both B- and T-cell-mediated immune responses and it can be evaluated as a new subunit vaccine candidate against brucellosis.http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=21;epage=21;aulast=GolshaniBrucellacloningfusion proteinin silico designL7/L12outer membrane protein 2b
spellingShingle Maryam Golshani
Melina Ghasemian
Nematollah Gheibi
Saeid Bouzari
In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
Advanced Biomedical Research
Brucella
cloning
fusion protein
in silico design
L7/L12
outer membrane protein 2b
title In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
title_full In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
title_fullStr In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
title_full_unstemmed In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
title_short In silico Design, and In vitro Expression of a Fusion Protein Encoding Brucella abortus L7/L12 and SOmp2b Antigens
title_sort in silico design and in vitro expression of a fusion protein encoding brucella abortus l7 l12 and somp2b antigens
topic Brucella
cloning
fusion protein
in silico design
L7/L12
outer membrane protein 2b
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=21;epage=21;aulast=Golshani
work_keys_str_mv AT maryamgolshani insilicodesignandinvitroexpressionofafusionproteinencodingbrucellaabortusl7l12andsomp2bantigens
AT melinaghasemian insilicodesignandinvitroexpressionofafusionproteinencodingbrucellaabortusl7l12andsomp2bantigens
AT nematollahgheibi insilicodesignandinvitroexpressionofafusionproteinencodingbrucellaabortusl7l12andsomp2bantigens
AT saeidbouzari insilicodesignandinvitroexpressionofafusionproteinencodingbrucellaabortusl7l12andsomp2bantigens